Clinical evaluation of a novel close-loop insulin delivery system in type 1 diabetes
Type 1 diabetes (T1DM) is managed by exogenous insulin administration, either by multiple daily injections (MDI) of insulin or via continuous subcutaneous insulin infusion (CSII). Despite intensive insulin therapy and structured education a significant proportion of people with T1DM are unable to ac...
Main Author: | |
---|---|
Other Authors: | |
Published: |
Imperial College London
2015
|
Subjects: | |
Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.749112 |